Siemens Offers Replays of Oncology Webinars
Each program has been designated for 1.0 PACE continuing education credit.
Read MoreSearch Results for: prostate cancer
NIH Offers Suggestion on Treatment of Prostate Cancer
An independent panel convened by the NIH has concluded that many men with localized, low-risk prostate cancer should be closely monitored, permitting treatment to be delayed until warranted by disease progression.
Read MoreStudy: Quanterix PSA Reliable Predictor of BCR-Free Survival
Quanterix Corp released results from a clinical evaluation of its Prostate Specific Antigen (PSA) test, a fifth-generation digital immunoassay.
Read MoreBioCurex Cancer Marker Blood Test More Accurate than FDA-Approved Free-PSA Test
BioCurex Inc’s RECAF cancer marker blood test has been shown to detect approximately 70% of stage I, 76% of stage II, 90% of stage III, and 100% of stage IV prostate cancers all with very high specificity.
Read More
Testing/Diagnostics
ARUP LaboratoriesBiohit IncBioneer IncMitsubishi Chemical Medience CorpSiemens Healthcare DiagnosticsHoefer IncAbbottArlington Scientific IncEraGen Biosciences
Read More